Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for Marijuana Cue-Reactivity
NCT02439814Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Jun 2015; status: completed.
02
Drugs
pregnenolone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT02439814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02439814.